According to our latest research, the global oncology companion diagnostic market size reached USD 7.2 billion in 2024, with a robust compound annual growth rate (CAGR) of 12.6% projected from 2025 to 2033. By leveraging this growth rate, the market is forecasted to attain a value of USD 20.9 billion by 2033. The primary driver behind this expansion is the increasing adoption of precision medicine, which is transforming cancer care by enabling more targeted and effective treatment approaches.
https://growthmarketreports.co....m/report/oncology-co